[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"company:KROS":3,"prompts:company:0001664710":22,"events:cik:0001664710":49},{"status":4,"company":5,"choices":20,"suggestions":21},"found",{"cik":6,"name":7,"ticker":8,"exchange":9,"listings":10,"delisted":15,"coverage":16},"0001664710","Keros Therapeutics, Inc.","KROS","NASD",[11],{"ticker":8,"glr_ticker":12,"exchange":9,"type":13,"delisted_on":14},"NASD:KROS","Common Stock",null,false,{"buybacks":17},{"published":18,"published_at":19},true,"2026-11-17",[],[],{"placement":23,"items":24},"company",[25,30,34,38,44],{"id":26,"title":27,"hint":28,"kind":29,"question":27,"target":14},"asr-3nc2","How does a 3nc2 ASR look for me?","Pricer · discount, size vs. ADV","analyze",{"id":31,"title":32,"hint":33,"kind":29,"question":32,"target":14},"compare-3nc2-6nc4","Compare 3nc2 vs 6nc4","Two pricers side by side",{"id":35,"title":36,"hint":37,"kind":29,"question":36,"target":14},"backtest-2y","Backtest an ASR over 2 years","Backtest · chart",{"id":39,"title":40,"hint":41,"kind":42,"question":14,"target":43},"outstanding","What do I have outstanding?","Public · no email needed","page","buybacks#outstanding",{"id":45,"title":46,"hint":47,"kind":48,"question":14,"target":14},"convert-terms","Terms for a new convert","Coming next","soon",{"view":50,"sort":51,"total":52,"generated_at":53,"items":54,"next_cursor":14},"all","newest",3,"2026-11-20T08:38:22.240717Z",[55,66,79],{"id":56,"type":57,"event_date":58,"company":59,"amount_usd":60,"amount_estimated":15,"shares":14,"headline":61,"source":62},"ae13bd01-0703-514f-92fd-6aca19174707","authorization_new","2026-11-16",{"cik":6,"name":7,"ticker":8,"exchange":9},5000000,"Keros Therapeutics, Inc. authorizes $5m share repurchase program",{"accession":63,"form":64,"as_of":58,"filed_at":58,"url":65},"0001664710-26-000072","8-K","https:\u002F\u002Fwww.sec.gov\u002FArchives\u002Fedgar\u002Fdata\u002F1664710\u002F000166471026000072\u002F",{"id":67,"type":68,"event_date":69,"company":70,"amount_usd":71,"amount_estimated":15,"shares":72,"headline":73,"source":74},"1fc0d656-d15e-5cd6-bba2-e8517573fed9","quarterly_repurchase","2026-09-30",{"cik":6,"name":7,"ticker":8,"exchange":9},1649274.3399999999,146342,"Keros Therapeutics, Inc. repurchased 146,342 shares ($2m) in the quarter to Sep 30, 2026",{"accession":75,"form":76,"as_of":69,"filed_at":77,"url":78},"0001664710-26-000066","10-Q","2026-11-05","https:\u002F\u002Fwww.sec.gov\u002FArchives\u002Fedgar\u002Fdata\u002F1664710\u002F000166471026000066\u002F",{"id":80,"type":57,"event_date":81,"company":82,"amount_usd":60,"amount_estimated":15,"shares":14,"headline":61,"source":83},"e0e4e2db-85b5-57f8-aa2e-d19e740dd435","2026-09-08",{"cik":6,"name":7,"ticker":8,"exchange":9},{"accession":75,"form":76,"as_of":69,"filed_at":77,"url":78}]